Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Epidemiology of prostate cancer

View through CrossRef
Prostate cancer is the second most common malignancy and the sixth most common cause of cancer death for men worldwide. The highest incidence and mortality rates are in populations that originated in Africa, such as African Americans. Rates are also high in Western countries and generally low in East and South Asia. Incidence rates are increasing in some countries which until recently had low rates, but are not changing much in countries which already have high rates. The only well-established risk factors are increasing age, African ancestry, family history of the disease, and certain genetic factors, none of which is modifiable. Many potential risk factors have been investigated in epidemiological studies and randomized trials. Observational studies have shown that prostate cancer risk is positively associated with the plasma concentration of insulin-like growth factor-I, but is not strongly associated with testosterone or other sex hormones. Studies of nutritional factors suggest that risk may be higher in men with a high intake of animal foods and dairy products, but this relationship is not clear enough to be considered as established. Some studies of other nutritional factors such as fat, lycopene and other carotenoids, vitamin D, vitamin E and selenium have suggested possible associations, but overall do not show any clear relationships. Research on other possible risk factors has shown a small positive association of risk with height, but little association with obesity, smoking or alcohol intake, and evidence on sexual behaviour and sexually transmitted infections is inconclusive. Further research is needed, particularly to determine whether potential risk factors may be related more to aggressive than to indolent prostate cancer.
Title: Epidemiology of prostate cancer
Description:
Prostate cancer is the second most common malignancy and the sixth most common cause of cancer death for men worldwide.
The highest incidence and mortality rates are in populations that originated in Africa, such as African Americans.
Rates are also high in Western countries and generally low in East and South Asia.
Incidence rates are increasing in some countries which until recently had low rates, but are not changing much in countries which already have high rates.
The only well-established risk factors are increasing age, African ancestry, family history of the disease, and certain genetic factors, none of which is modifiable.
Many potential risk factors have been investigated in epidemiological studies and randomized trials.
Observational studies have shown that prostate cancer risk is positively associated with the plasma concentration of insulin-like growth factor-I, but is not strongly associated with testosterone or other sex hormones.
Studies of nutritional factors suggest that risk may be higher in men with a high intake of animal foods and dairy products, but this relationship is not clear enough to be considered as established.
Some studies of other nutritional factors such as fat, lycopene and other carotenoids, vitamin D, vitamin E and selenium have suggested possible associations, but overall do not show any clear relationships.
Research on other possible risk factors has shown a small positive association of risk with height, but little association with obesity, smoking or alcohol intake, and evidence on sexual behaviour and sexually transmitted infections is inconclusive.
Further research is needed, particularly to determine whether potential risk factors may be related more to aggressive than to indolent prostate cancer.

Related Results

Prostate-specific antigen and biomarkers for prostate cancer
Prostate-specific antigen and biomarkers for prostate cancer
Prostate-specific antigen (PSA) is a kallikrein serine protease secreted by the prostate to liquefy the ejaculatory coagulum. Changes in the blood/prostate barrier allows PSA to en...
Prostate Cancer: the facts
Prostate Cancer: the facts
Abstract Prostate cancer is the second leading cause of cancer death in men. Figures from the US show that the average male stands a one in five chance of developing...
Prevention of cancer
Prevention of cancer
In the UK, the four commonest cancers—lung cancer, breast cancer, colon cancer, and prostate cancer—result in around 62 000 deaths every year. Although deaths from cancer have fall...
Applied Epidemiology
Applied Epidemiology
Abstract Focusing on areas of public health practice in which the systematic application of epidemiologic methods can have a large and positive impact, this text ...
Accomplishments in Cancer Epidemiology
Accomplishments in Cancer Epidemiology
In his chapter “Accomplishments in Cancer Epidemiology,” Dr. MacMahon summarizes the history of the discipline, particularly the epidemiologic evidence on cigarette smoking, ionizi...
Prostate Cancer
Prostate Cancer
Prostate cancer is one of the most common malignancies in men in the Western world. Although a wide range of treatment regimens are available for this disease, there are few eviden...
Clinical approach to suspected cancer
Clinical approach to suspected cancer
Lung cancer 4Breast cancer 5Urological cancer 6Nervous system tumours 7Upper gastrointestinal cancer 8Lower gastrointestinal cancer 9Gynaecological cancer 10Haematological cancer 1...
Biomarkers in Cancer Epidemiology
Biomarkers in Cancer Epidemiology
Biomarkers have played an important role in cancer epidemiology since the 1980s. Their integration may be used in several ways, including to measure exposures or exposure dose, to ...

Back to Top